
Dr. Eric Rullier, MD, PhD, FASCRS, is Chairman and Professor of Surgery for the Colorectal Unit within the Department of Surgery at Saint-André Hospital (Bordeaux, France). Due to his extensive expertise in the field, he serves as Chairman for Education in General Surgery in France (South section). Proof of his expertise in the field lie in his numerous publications as author or co-author in renowned scientific journals and his participation on more than 300 conferences. In 1991, Dr. Eric Rullier, MD, PhD, FASCRS graduated in digestive surgery and as a consultant surgeon in colorectal surgery from the University of Bordeaux in 1995. Dr. Rullier is a board member of several medical societies across Europe: he belongs to the Educational and Research Boards of the European Society of Coloproctology (ESCP), and he is a member of the Publication Committee of the European Association for Endoscopic Surgery (EAES). In 2005, Dr. Eric Rullier founded the GRECCAR (Groupe de REcherche Chirurgical du Cancer Rectal) to develop innovative research in rectal cancer at a national level. In 2015, he also co-founded PELVICARE at Bordeaux Foundation University, to develop the Bordeaux Colorectal School, and is Director of European courses and Masterclasses for TME and colorectal surgery. Regarding his work in research, Dr. Rullier developed clinical research in rectal cancer. His main research topics focus on low rectal cancer, sphincter and organ preservation, and minimally invasive surgery. He demonstrated the oncologic safety of the intersphincteric resection technique and participated in the European development of laparoscopic surgery in rectal cancer. He also proposed a classification of low rectal cancer to standardize surgery and facilitate sphincter preservation.
Selected publications from PubMed
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.
Faucheron JL, Tidadini F, Lakkis Z, Jafari M, Germain A, Rullier E, Lefevre J, Tuech JJ, Kartheuser A, Leonard D, Prudhomme M, Piessen G, Regimbeau JM, Cotte E, Duprez D, Badic B, Panis Y, Rivoire M, Meunier B, Portier G, Bosson JL, Vilotitch A, Foote A, Fischer J, Caspar Y, Rouanet P, Trilling B, GRECCAR study Group
Acta Chir Belg. 2026 Oct;126(5):188-194 doi: 10.1080/00015458.2026.2682162.
Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive Resection Is Not a Risk Factor.
Fernandez LM, Vailati BB, São Julião GP, Corbi LE, Elias F, Habr-Gama A, Azevedo JM, Santiago IA, Parés O, Parvaiz A, Vendrely V, Rullier A, Rullier E, Denost Q, Perez RO
Dis Colon Rectum. 2025 Oct 1;68(10):1154-1161 doi: 10.1097/DCR.0000000000003834.
Risk factors and risk prediction modelling for pelvic sepsis and anastomotic leak following robotic total mesorectal excision with primary anastomosis for rectal cancer.
Fleming CA, Geitenbeek RTJ, Duhoky R, Moussion A, Bouazza N, Khan J, Cotte E, Dubois A, Rullier E, Hompes R, Rouanet P, Consten ECJ, Denost Q, EUREKA collaborative
Colorectal Dis. 2025 Aug;27(8):e70188 doi: 10.1111/codi.70188.
Predictors and risk model for positive circumferential resection margin after robot-assisted total mesorectal excision: retrospective cohort study.
Geitenbeek RTJ, Burghgraef TA, Duhoky R, Fleming CA, Moussion A, Bouazza N, Cotte E, Dubois A, Rullier E, Denost Q, Rouanet P, Khan J, Hompes R, Consten ECJ, EUREKA study group
BJS Open. 2025 May 7;9(3) doi: 10.1093/bjsopen/zraf027.
An International Multicentre Retrospective Cohort Study Evaluating Robot-Assisted Total Mesorectal Excision in Experienced Dutch, French, and United Kingdom Centres-The EUREKA Collaborative.
Geitenbeek RTJ, Genders CMS, Taoum C, Duhoky R, Burghgraef TA, Fleming CA, Cotte E, Dubois A, Rullier E, Denost Q, Khan JS, Hompes R, Rouanet P, Consten ECJ, EUREKA Study Group
Cancers (Basel). 2025 Apr 9;17(8) doi: 10.3390/cancers17081268.
Help your network discover Dr. Eric Rullier's clinical expertise.